Eli Lilly and Company
Foreign stocks · NYSE · Healthcare · Pharmaceuticals
A US drug company whose main revenue is GLP-1 diabetes and weight-loss drugs such as Mounjaro and Zepbound, followed by cancer and immunology drugs
For every 100 dollars of sales: cost of sales 17 · operating expenses 43 · tax and other items 9 · leaving 32 as net profit
Investors in Thailand can buy LLY through 79 mutual funds open to retail investors. Most of them (78 funds) don't buy the stock themselves. Instead they invest in a master fund abroad, which in turn holds LLY.
| Fund | LLY weight | How it invests | 1-year return |
|---|---|---|---|
 TUSHEALTH-ATISCO US Healthcare Fund | 14.91% | Via XLV | +23.08% |
| TGHRMF-ATISCO Global Healthcare RMF | 10.15% | Via several master funds (ISHARES GLOBAL HEALTHCARE, State Street Health Care Select Sector SPDR, ISHARES BIOTECHNOLOGY) | +20.61% |
 MHEALTHGMFC Health Innovation Fund | 9.76% | Via BGF World Healthscience Fund | +17.59% |
 SCBGHCSCB GLOBAL HEALTH CARE EQUITY FUND | 9.72% | Via Janus Henderson Global Life Sciences Fund | +19.10% |
| SCBIHEALT(SSFE)SCB Healthcare Innovation | 9.59% | Via BNP Paribas Funds Health Care Innovators | +15.53% |
 KT-HEALTHCARE-AKTAM World Healthcare Fund | 9.58% | Via Janus Henderson Global Life Sciences Fund | +20.31% |
| MHEALTHRMFMFC Health Innovation Retirement Fund | 9.55% | Via BGF World Healthscience Fund | +18.34% |
| SCBRMGHCSCB GLOBAL HEALTH CARE RMF | 9.53% | Via Janus Henderson Global Life Sciences Fund | +19.18% |
| KT-HEALTHC RMFKTAM World Healthcare RMF | 9.51% | Via Janus Henderson Global Life Sciences Fund | +20.06% |
 KKP GHC-AKKP GLOBAL HEALTH CARE FUND | 9.51% | Via Janus Henderson Global Life Sciences Fund | +18.96% |
Yearly average over the last 4 years · Latest annual sales 65.2B USD
For every 100 dollars of sales, about 32 dollars is left as net profit
Per year, relative to the share price · Tech stocks tend to pay little because they reinvest their profits
Now close to its 1-year high
| Item (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total revenue | 28.3B USD | 28.5B USD | 34.1B USD | 45.0B USD | 65.2B USD |
| Gross profit | 21.0B USD | 21.9B USD | 27.0B USD | 36.6B USD | 54.1B USD |
| Net profit | 5.6B USD | 6.2B USD | 5.2B USD | 10.6B USD | 20.6B USD |
| EPS (diluted) | 6.12 | 6.90 | 5.80 | 11.71 | 22.95 |
| Gross margin | 74.2% | 76.8% | 79.2% | 81.3% | 83.0% |
| Net margin | 19.7% | 21.9% | 15.4% | 23.5% | 31.7% |
| Operating cash flow | 7.4B USD | 7.6B USD | 4.2B USD | 8.8B USD | 16.8B USD |
| Free cash flow | 6.1B USD | 5.7B USD | 792.0M USD | 3.8B USD | 9.0B USD |
| Total assets | 48.8B USD | 49.5B USD | 64.0B USD | 78.7B USD | 112.5B USD |
| Total liabilities | 39.7B USD | 38.7B USD | 53.1B USD | 64.4B USD | 85.9B USD |
| Shareholders' equity | 9.2B USD | 10.8B USD | 10.9B USD | 14.3B USD | 26.5B USD |
| Period | SMA | EMA | Price vs line |
|---|---|---|---|
| 10 days | 1,345.91 | 1,356.26 | Above |
| 20 days | 1,283.46 | 1,304.48 | Above |
| 50 days | 1,207.19 | 1,239.11 | Above |
| 100 days | 1,195.25 | 1,188.51 | Above |
| 200 days | 1,096.87 | 1,115.65 | Above |
| Indicator | Value | Signal |
|---|---|---|
| RSI(14) | 76.56 | Down |
| MACD(12,26) | 59.23 | Up |
| ADX(14) | 44.97 | Neutral |
| ATR(14) % of price | 1.39 | Neutral |
The many funds holding less than 3% are usually index funds holding at market weight · Funds holding more than 8% have deliberately chosen a large position
BBLAM14
UOBAM12
EASTSPRING10TISCOASSET7KTAM7
KASSET7MFC5KKPAM5| Fund | LLY weight | Master fund | 1-year return | TER |
|---|---|---|---|---|
| TUSHEALTH-A | 14.91% | XLV | +23.08% | 1.31% |
| TGHRMF-A | 10.15% | several master funds (ISHARES GLOBAL HEALTHCARE, State Street Health Care Select Sector SPDR, ISHARES BIOTECHNOLOGY) | +20.61% | 1.60% |
| MHEALTHG | 9.76% | BGF World Healthscience Fund | +17.59% | 2.00% |
| SCBGHC | 9.72% | Janus Henderson Global Life Sciences Fund | +19.10% | 1.72% |
| SCBIHEALT(SSFE) | 9.59% | BNP Paribas Funds Health Care Innovators | +15.53% | 0.11% |
| KT-HEALTHCARE-A | 9.58% | Janus Henderson Global Life Sciences Fund | +20.31% | 1.34% |
| MHEALTHRMF | 9.55% | BGF World Healthscience Fund | +18.34% | 1.81% |
| SCBRMGHC | 9.53% | Janus Henderson Global Life Sciences Fund | +19.18% | 1.18% |
| KT-HEALTHC RMF | 9.51% | Janus Henderson Global Life Sciences Fund | +20.06% | 1.97% |
| KKP GHC-A | 9.51% | Janus Henderson Global Life Sciences Fund | +18.96% | 1.21% |
| ES-HEALTHCARERMF | 9.38% | Janus Henderson Global Life Sciences Fund | +18.85% | 1.78% |
| ES-HEALTHCARE | 9.37% | Janus Henderson Global Life Sciences Fund | +19.67% | 1.24% |
 LHHEALTH-A | 9.14% | AB International Health Care Portfolio | +18.58% | 2.16% |
 FP HCARE-A | 8.91% | Manulife Global Fund – Healthcare Fund | +26.97% | 2.19% |
| UHCRMF | 8.53% | United Global Healthcare Fund | +15.57% | 1.86% |
| BCARERMF | 8.45% | Wellington Global Health Care Equity Fund | +22.64% | 1.48% |
| UGH | 8.45% | United Global Healthcare Fund | +15.64% | 1.88% |
| UOBSHC | 8.45% | United Global Healthcare Fund | +15.82% | 1.86% |
| BCARE | 8.44% | Wellington Global Health Care Equity Fund | +23.02% | 1.24% |
| BCARESSF | 8.39% | Wellington Global Health Care Equity Fund | +22.81% | 1.23% |
| Fund | LLY weight | Master fund | 1-year return | TER |
|---|---|---|---|---|
| K-GHEALTH | 8.17% | JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | +16.26% | 1.75% |
| K-GHRMF | 8.17% | JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | +16.44% | 1.74% |
 ASP-X | 8.14% | Buys the stock directly | −11.89% | 2.96% |
 KFHHCARE-A | 7.97% | JPMorgan Funds - Global Healthcare Fund | +15.06% | 1.54% |
| KFHCARERMF | 7.94% | JPMorgan Funds - Global Healthcare Fund | +15.68% | 1.54% |
| KFHEALTH-A | 7.92% | JPMorgan Funds - Global Healthcare Fund | +23.48% | 1.53% |
| K-GHEALTH(UH) | 7.75% | JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | +22.56% | 1.76% |
| TGHSTARP | 5.91% | several master funds (BlackRock Global Funds - World Healthscience) | +15.44% | 1.90% |
| M-USEQUH | 4.97% | Morgan Stanley Investment Funds US Core Equity Fund | +5.26% | 1.09% |
| M-USEQH | 4.92% | Morgan Stanley Investment Funds US Core Equity Fund | −0.53% | 1.07% |
| LHLONGEVITY | 4.51% | CANC | N/A | 2.10% |
| M-EDGE | 4.29% | BGF Global Long-Horizon Equity Fund | −6.86% | 1.96% |
| ES-GCG-A | 4.18% | Amundi Funds Polen Capital Global Growth Fund | −15.02% | 1.78% |
| ES-GCGRMF | 4.17% | Amundi Funds Polen Capital Global Growth Fund | −14.94% | 1.77% |
| TGHDIGI | 3.98% | UBS (Lux) Digital Health Equity | +3.88% | 1.29% |
| KT-WTAI-A | 3.91% | Allianz Global Artificial Intelligence | +0.89% | 1.54% |
| KFFUTUREGEN-A | 3.83% | Goldman Sachs Global Future Generations Equity Portfolio | −8.07% | 1.54% |
| KT-WTAI RMF | 3.71% | Allianz Global Artificial Intelligence | +0.86% | 1.35% |
| ES-USBLUECHIP | 3.07% | T. Rowe Price Funds SICAV — US Blue Chip Equity Fund (Master Fund) | −7.71% | 1.80% |
| ES-USBLUECHIP-UH | 3.03% | T. Rowe Price Funds SICAV — US Blue Chip Equity Fund (Master Fund) | −0.78% | 1.97% |
| K-USA-A(A) | 2.92% | JPMorgan Funds - US Growth Fund | −13.08% | 1.72% |
| UUSA | 2.92% | JPMorgan Funds - US Growth Fund | −9.86% | 1.85% |
| K-USARMF | 2.91% | JPMorgan Funds - US Growth Fund | −13.03% | 1.70% |
| B-USALPHASSF | 2.89% | JPMorgan Funds - US Growth Fund | −5.27% | 1.56% |
| KT-US-A | 2.88% | AB American Growth Portfolio | −3.26% | 1.54% |
| B-USALPHARMF | 2.88% | JPMorgan Funds - US Growth Fund | −5.18% | 1.46% |
| B-USALPHA | 2.87% | JPMorgan Funds - US Growth Fund | −5.45% | 1.53% |
| KT-US RMF | 2.86% | AB American Growth Portfolio | −3.30% | 1.15% |
| B-GTO | 2.69% | Wellington Global Innovation Fund | +2.91% | 1.19% |
| B-GTOSSF | 2.68% | Wellington Global Innovation Fund | +2.93% | 1.22% |
| B-GTORMF | 2.67% | Wellington Global Innovation Fund | +2.85% | 1.21% |
| USUSRMF | 2.66% | Allianz Global Investors Fund - Allianz Global Sustainability Share Class PT (USD) | −3.48% | 1.87% |
| USUS | 2.66% | Allianz Global Investors Fund - Allianz Global Sustainability Share Class PT (USD) | −3.41% | 1.85% |
| UGSTAR | 2.60% | Robeco Global Stars Equities IL USD | +1.62% | 1.86% |
| UNI | 2.57% | United Global Innovation Fund Class T USD Acc | −1.33% | 1.96% |
| UNIRMF | 2.53% | United Global Innovation Fund Class A USD Acc | −1.47% | 2.00% |
| SCBGQUAL(A) | 2.51% | IWQU | +10.43% | 1.18% |
| KT-WQUALITY-A | 2.48% | IWQU | +11.17% | 0.70% |
| TGQUALITY-UH | 2.47% | IWQU | +17.59% | 1.32% |
| TGQUALITYRMF-A | 2.46% | IWQU | +10.52% | 1.42% |
| TGQUALITY-A | 2.45% | IWQU | +10.34% | 1.27% |
| B-FUTURERMF | 2.13% | several master funds | +0.82% | 1.81% |
| B-GLOBAL | 2.09% | Wellington Global Quality Growth Fund | +5.29% | 1.22% |
| B-FUTURE | 2.08% | several master funds | −0.28% | 1.81% |
| B-GLOBALRMF | 2.08% | Wellington Global Quality Growth Fund | +5.08% | 1.24% |
| ES-GQGRMF | 2.05% | Wellington Global Quality Growth Fund | +0.76% | 1.84% |
| ES-GQG | 2.05% | Wellington Global Quality Growth Fund | +0.70% | 1.79% |
| ES-GQG-UH | 2.03% | Wellington Global Quality Growth Fund | +7.79% | 1.56% |
| KKP GNP | 1.69% | Capital Group New Perspective Fund (Master Fund) | +6.56% | 1.74% |
| KKP GNP RMF-UH | 1.69% | Capital Group New Perspective Fund (Master Fund) | +6.53% | 1.75% |
| KKP GNP-H | 1.69% | Capital Group New Perspective Fund (Master Fund) | −1.09% | 1.74% |
| KKP GNP RMF-H | 1.68% | Capital Group New Perspective Fund (Master Fund) | −1.14% | 1.75% |
| ES-AALF-A | 1.33% | several master funds | +3.30% | 1.58% |
| BCAP-XHEALTH | 1.21% | several master funds | +17.62% | 1.23% |
| K-GARMF | 1.10% | BGF Global Allocation Fund | +2.27% | 1.23% |
| K-GA-A(A) | 1.09% | BGF Global Allocation Fund | +2.35% | 1.18% |
| UOBSGA | 1.07% | BGF Global Allocation Fund | +1.26% | 1.21% |
| UOBGARMF | 1.07% | BGF Global Allocation Fund | +1.42% | 1.22% |
| UUSL-USD | 0.59% | T. ROWE PRICE FUNDS SICAV – US LARGE CAP GROWTH EQUITY FUND | N/A | 1.86% |
| Master fund | Thai funds using this route | Master fund's LLY weight |
|---|---|---|
| Janus Henderson Global Life Sciences Fund | 7 | 9.72% |
| JPMorgan Funds - US Growth Fund | 6 | 2.92% |
| iShares Edge MSCI World Quality Factor UCITS ETF | 5 | 2.51% |
| Wellington Global Quality Growth Fund | 5 | 2.09% |
| several master funds | 4 | 2.13% |
| Capital Group New Perspective Fund (Master Fund) | 4 | 1.69% |
| BGF Global Allocation Fund | 4 | 1.10% |
| United Global Healthcare Fund | 3 | 8.53% |
| Wellington Global Health Care Equity Fund | 3 | 8.45% |
| JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | 3 | 8.17% |
| JPMorgan Funds - Global Healthcare Fund | 3 | 7.97% |
| Wellington Global Innovation Fund | 3 | 2.69% |
| BGF World Healthscience Fund | 2 | 9.76% |
| Morgan Stanley Investment Funds US Core Equity Fund | 2 | 4.97% |
| Amundi Funds Polen Capital Global Growth Fund | 2 | 4.18% |
